Claus Vogelmeier
Department of Respiratory Medicine
University of Marburg
Baldingerstrasse
35043 Marburg
Germany
Name/email consistency: high
- Treating the systemic effects of chronic obstructive pulmonary disease. Vogelmeier, C.F., Wouters, E.F. Proc. Am. Thorac. Soc (2011)
- Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients. Vogelmeier, C., Verkindre, C., Cheung, D., Galdiz, J.B., Güçlü, S.Z., Spangenthal, S., Overend, T., Henley, M., Mizutani, G., Zeldin, R.K. Pulm. Pharmacol. Ther (2010)
- Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study. Vogelmeier, C., Kardos, P., Harari, S., Gans, S.J., Stenglein, S., Thirlwell, J. Respir. Med (2008)
- Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?. Vogelmeier, C., D'Urzo, A., Pauwels, R., Merino, J.M., Jaspal, M., Boutet, S., Naya, I., Price, D. Eur. Respir. J. (2005)